(Q28032484)

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Cell cycle. Piecing together the p53 puzzle.

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

https://api.crossref.org/works/10.1038%2F35042675

1 reference

7 January 2021

https://api.crossref.org/works/10.1038%2F35042675

1 reference

7 January 2021

Mechanisms of switching on p53: a role for covalent modification?

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

MDM2--master regulator of the p53 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

The complexity of p53 modulation: emerging patterns from divergent signals

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Reactivation of mutant p53: a new strategy for cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Mouse models dissect the role of p53 in cancer and development

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

The ins and outs of p53

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Regulation of p53 downstream genes.

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

https://api.crossref.org/works/10.1038%2F35042675

1 reference

7 January 2021

Dysregulation of apoptosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

The activity of the murine Bax promoter is regulated by Sp1/3 and E-box binding proteins but not by p53

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

p53 sends nucleotides to repair DNA.

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

De-mystifying the mechanism(s) of maspin

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Identification and classification of p53-regulated genes

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Error and attack tolerance of complex networks

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

How robust is the Internet?

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Signal transduction pathways controlling the switch between keratinocyte growth and differentiation

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

1 reference

https://api.crossref.org/works/10.1038%2F35042675

7 January 2021